425

Prospectus/Communication re Business Combination

Lineage Cell Therapeutics, Inc. Filed 2012-10-18 Acc 0001157523-12-005178

Documents 1

425 Prospectus/Communication re Business Combination , a50445743.htm

Around this filing

2018-11-08 425 Prospectus/Communication re Business Combination
2012-10-23 8-K Regulation FD disclosure
2012-10-19 8-K Regulation FD disclosure
2012-10-18 425 Prospectus/Communication re Business Combination

Link to a passage

External

SEC EDGAR (opens in new tab)